Tumor size>5cm is a line of demarcation of mortality and progression of gastric cancer after D2+gastrectomy for Chinese population

Yifan Li, Hanliang Zhao, Yinan Shi, Ruirui Yang
doi: https://doi.org/10.1101/2023.12.10.23299776

Article Information

doi 
https://doi.org/10.1101/2023.12.10.23299776
History 
  • December 11, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Yifan Li1,
  2. Hanliang Zhao2,*,
  3. Yinan Shi3,* and
  4. Ruirui Yang4,*
  1. 1Shanxi Medical University, Chinese Academy of Medical Sciences, Second Department of General Surgery, Shanxi Province Carcinoma Hospital, Carcinoma Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, 030013, Peoples R China
  2. 2Shanxi Medical University, Department of Hepatobiliary Surgery, Shanxi Bethune Hospital, Taiyuan, Shanxi, 030013, Peoples R China
  3. 3Department of Gastroenterology and Hepatology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030013, Shanxi Province, China
  4. 4School of Clinical and Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250000, China
  1. ↵*Correspondence author: Haoliang Zhao liyifan1980{at}hotmail.com, Yinan Shi elizabethen{at}126.com, Ruirui Yang yangruirui2008{at}126.com
Back to top
Posted December 11, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Tumor size>5cm is a line of demarcation of mortality and progression of gastric cancer after D2+gastrectomy for Chinese population
Yifan Li, Hanliang Zhao, Yinan Shi, Ruirui Yang
medRxiv 2023.12.10.23299776; doi: https://doi.org/10.1101/2023.12.10.23299776
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area